| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.7M | +62.6% |
| Cost of Revenue | $2.1M | +47.4% |
| Gross Profit | $567K | +163.7% |
| R&D Expense | $725K | -11.5% |
| SG&A Expense | $5.2M | +16.8% |
| Net Income | -$7.6M | +2.3% |
| EPS (Basic) | -$1.90 | +63.4% |
| EPS (Diluted) | -$1.90 | +63.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | +147.7% |
| Accounts Receivable | $142K | +31.7% |
| Inventory | $1.7M | +109.8% |
| Current Assets | $9.4M | +2.1% |
| Total Assets | $10.1M | +3.1% |
| Current Liabilities | $1.0M | +41.7% |
| Total Liabilities | $1.1M | +44.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | -7.9% |
| Capital Expenditures | $73K | +16.6% |
| Investing Cash Flow | $4.5M | +186.7% |
| Financing Cash Flow | $6.7M | -34.8% |
| Free Cash Flow | -$7.3M | -8.0% |
| $9.1M |
| -0.3% |